The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial.
Journal Information
Full Title: Orphanet J Rare Dis
Abbreviation: Orphanet J Rare Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study has received ethical approval from the Dutch Medical Ethical Review Committee NedMec (registration number 22-1005/Gm-G) and from the Dutch Central Committee on Research Involving Human Subjects (CCMO). Written informed consent will be obtained from all participants. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study has received funding from the Dutch Brain Foundation (in Dutch: Hersenstichting, grant number DR-2021-00387). The funder had no role in the design of this study and will not have any role during its execution, analyses, and interpretation of the data."
"Trial registration ClinicalTrials.gov, NCT05662111. Registered 22 December 2022, https://clinicaltrials.gov/ct2/show/NCT01585402."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025